First Affiliated Hospital Xi'an Jiaotong University
Clinical trials sponsored by First Affiliated Hospital Xi'an Jiaotong University, explained in plain language.
-
Race against time: new drug could extend stroke treatment window
Disease control Not yet recruitingThis study is testing if giving a clot-dissolving drug (rhPro-UK) by IV before a standard clot-removal surgery helps people recover better from a major stroke. It focuses on patients who arrive for treatment 4.5 to 24 hours after their stroke symptoms began, which is later than t…
Phase: PHASE3 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Double-Punch T-Cells take aim at stubborn blood cancers
Disease control Not yet recruitingThis early study is testing a new type of cell therapy for patients whose B-cell lymphoma has come back or hasn't responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to attack two specific targets on the cancer cells (CD19 and CD…
Phase: EARLY_PHASE1 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC